Ratios from the company's XBRL filings, latest filings
Revenue, TTM
n/a
fewer than four consecutive quarters of revenue filed
Revenue, TTM CHRN
FY May 2026
n/a
FY Dec 2025
n/a
FY May 2025
$17.5M
FY Dec 2024
$17.9M
FY May 2024
$17.9M
Aug 2026
$41.5M
Mar 2026
$2.1M
Dec 2025
$3.1M
Sep 2025
$4.2M
Aug 2025
$16.7M
Jun 2025
$2.1M
Mar 2025
$3.4M
Dec 2024
$5.1M
At each fiscal year end
Single quarter
Net margin, TTM
n/a
needs four consecutive quarters of both revenue and net income
Net margin, TTM CHRN
FY May 2026
n/a
FY Dec 2025
n/a
FY May 2025
-61.5%
FY Dec 2024
-63.2%
FY May 2024
-79.5%
Aug 2026
-102.4%
Mar 2026
-321.6%
Dec 2025
-148.9%
Sep 2025
-33.6%
Aug 2025
-67.3%
Jun 2025
-131.7%
Mar 2025
-85.7%
Dec 2024
-67.1%
At each fiscal year end
Single quarter
Free cash flow, TTM
n/a
fewer than four consecutive quarters of operating cash flow
Free cash flow, TTM CHRN
FY May 2026
n/a
FY Dec 2025
n/a
FY May 2025
-$8.4M
FY Dec 2024
-$9.9M
FY May 2024
-$11.4M
Aug 2026
$11.6M
Mar 2026
-$2.1M
Dec 2025
-$4.5M
Sep 2025
-$2.1M
Aug 2025
-$882.0K
Jun 2025
-$3.5M
Mar 2025
-$2.0M
Dec 2024
-$1.5M
At each fiscal year end
Single quarter
Debt to equity
0.07x
long-term 2026-08-31 plus current 2026-08-31; equity 2026-08-31
Debt to equity CHRN
FY May 2026
0.02x
FY Dec 2025
1.33x
FY May 2025
0.16x
FY Dec 2024
0.16x
FY May 2024
0.14x
Aug 2026
0.07x
Mar 2026
5.74x
Dec 2025
1.33x
Sep 2025
1.24x
Aug 2025
0.13x
Jun 2025
1.10x
Mar 2025
0.16x
Dec 2024
0.16x
At each fiscal year end
Trailing four quarters at each quarter end
Cash flow to debt
n/a
needs four quarters of operating cash flow
Cash flow to debt CHRN
FY May 2026
n/a
FY Dec 2025
n/a
FY May 2025
-4.18x
FY Dec 2024
-4.93x
FY May 2024
-5.66x
Aug 2026
n/a
Mar 2026
n/a
Dec 2025
n/a
Sep 2025
n/a
Aug 2025
n/a
Jun 2025
-0.76x
Mar 2025
-4.18x
Dec 2024
-4.93x
At each fiscal year end
Trailing four quarters at each quarter end
Return on equity
n/a
fewer than four consecutive quarters of net income
Return on equity CHRN
FY May 2026
n/a
FY Dec 2025
n/a
FY May 2025
-80.7%
FY Dec 2024
-89.5%
FY May 2024
-80.6%
Aug 2026
n/a
Mar 2026
n/a
Dec 2025
n/a
Sep 2025
n/a
Aug 2025
n/a
Jun 2025
-96.4%
Mar 2025
-80.7%
Dec 2024
-89.5%
At each fiscal year end
Trailing four quarters at each quarter end
Return on assets
n/a
fewer than four consecutive quarters of net income
Return on assets CHRN
FY May 2026
n/a
FY Dec 2025
n/a
FY May 2025
-38.4%
FY Dec 2024
-40.8%
FY May 2024
-43.1%
Aug 2026
n/a
Mar 2026
n/a
Dec 2025
n/a
Sep 2025
n/a
Aug 2025
n/a
Jun 2025
-44.2%
Mar 2025
-38.4%
Dec 2024
-40.8%
At each fiscal year end
Trailing four quarters at each quarter end
Return on invested capital
n/a
fewer than four consecutive quarters of operating income
Return on invested capital CHRN
FY May 2026
n/a
FY Dec 2025
n/a
FY May 2025
n/a
FY Dec 2024
n/a
FY May 2024
n/a
Aug 2026
n/a
Mar 2026
n/a
Dec 2025
n/a
Sep 2025
n/a
Aug 2025
n/a
Jun 2025
n/a
Mar 2025
n/a
Dec 2024
n/a
At each fiscal year end
Trailing four quarters at each quarter end
Return on capital employed
n/a
fewer than four consecutive quarters of operating income
Return on capital employed CHRN
FY May 2026
n/a
FY Dec 2025
n/a
FY May 2025
-52.7%
FY Dec 2024
-52.4%
FY May 2024
-56.6%
Aug 2026
n/a
Mar 2026
n/a
Dec 2025
n/a
Sep 2025
n/a
Aug 2025
n/a
Jun 2025
-68.8%
Mar 2025
-52.7%
Dec 2024
-52.4%
At each fiscal year end
Trailing four quarters at each quarter end
P/E, trailing
n/a
fewer than four consecutive quarters of diluted EPS
P/E, trailing CHRN
FY May 2026
n/a
FY Dec 2025
n/a
FY May 2025
n/a
FY Dec 2024
n/a
FY May 2024
n/a
Aug 2026
n/a
Mar 2026
n/a
Dec 2025
n/a
Sep 2025
n/a
Aug 2025
n/a
Jun 2025
n/a
Mar 2025
n/a
Dec 2024
n/a
At each fiscal year end
Trailing four quarters at each quarter end
Enterprise value
$2.1B
market value at close 2026-10-23 on 2026-10-13 shares, plus long-term 2026-08-31 plus current 2026-08-31, minus cash 2026-08-31
Enterprise value CHRN
FY May 2026
$59.6M
FY Dec 2025
$33.5M
FY May 2025
$131.2M
FY Dec 2024
$198.8M
FY May 2024
$306.7M
Aug 2026
$2.6B
Mar 2026
$46.0M
Dec 2025
$33.5M
Sep 2025
$22.7M
Aug 2025
$16.6M
Jun 2025
$102.3M
Mar 2025
$144.0M
Dec 2024
$198.8M
At each fiscal year end
Trailing four quarters at each quarter end
FCF yield
n/a
fewer than four consecutive quarters of operating cash flow
FCF yield CHRN
FY May 2026
n/a
FY Dec 2025
n/a
FY May 2025
-6.4%
FY Dec 2024
-4.9%
FY May 2024
-3.6%
Aug 2026
n/a
Mar 2026
n/a
Dec 2025
n/a
Sep 2025
n/a
Aug 2025
n/a
Jun 2025
-9.6%
Mar 2025
-5.6%
Dec 2024
-4.9%
At each fiscal year end
Trailing four quarters at each quarter end
PEG, trailing
n/a
fewer than four consecutive quarters of diluted EPS
PEG, trailing CHRN
FY May 2026
n/a
FY Dec 2025
n/a
FY May 2025
n/a
FY Dec 2024
n/a
FY May 2024
n/a
Aug 2026
n/a
Mar 2026
n/a
Dec 2025
n/a
Sep 2025
n/a
Aug 2025
n/a
Jun 2025
n/a
Mar 2025
n/a
Dec 2024
n/a
At each fiscal year end
Trailing four quarters at each quarter end
Price as of 2026-10-23. Hover or tap a tile for its yearly and quarterly history.Method
TTM is four consecutive fiscal quarters; Q4 is the year minus nine months when not filed. Returns use the average of opening and closing balances. EBIT is approximated by operating income. PEG uses trailing EPS growth.
Fundamentals
Annual figures from XBRL filings. Pick a past date to see them as known then.
CHRN ranks highest on growth (99th percentile) and financial health (81st), and lowest on institutional and government (21st), among Industrials peers.
Financial health
81
Inputs
Debt to equity0.07x · 81 pct, sector of 214
Cash flow to debtneeds four quarters of operating cash flow
Growth
100
Inputs
Revenue growth, YoY+459.4% · 100 pct, sector of 254
Backlog growth, YoYno backlog line filed, or no year-earlier backlog
Institutional and government
21
Inputs
Funds adding, latest quarter46 · 21 pct, sector of 201
Congress net buyers, 365dno Congress trades in 365 days
Federal contracts, 180dno federal contracts in 180 days
Lobbying spend, 4 quartersno lobbying filings in the last four quarters
Risk and compliance
38
Inputs
Short interest, % of float+14.0% · 10 pct, sector of 269
Recalls per $1B revenue, 3ynot measured for this sector, almost no peer has an event
EPA cases per $1B revenue, 5y0.00 per $1B · 100 pct, sector of 191
New text in Risk Factors, latest 10-K+55.4% · 3 pct, sector of 197
3 not measured: Profitability, Insider conviction, US patents
Profitability needs 2 of 4 inputs, 0 present: fewer than four consecutive quarters of net income; fewer than four consecutive quarters of operating income
Insider conviction needs 1 of 2 inputs, 0 present: no Form 4 purchase or sale (code P or S) in 180 days; no insider trades in 180 days
US patents needs 1 of 2 inputs, 0 present: patent data not loaded yet
4 of 7 axes scored. Each is a percentile against sector peers (all companies when the sector is thin); higher is better. An unscored axis is unmeasured, not low. How it is scored
CHRN filings, in plain words
Read the full summary
1 activist Schedule 13D filing in the last 180 days declared an intent to influence the company, the largest for 97.5% of the class. Each figure is counted from SEC and House filings as of 2026-10-27, dated the day the filing was made public.
Explore insider trading and ownership data
Every company we track, ranked by each kind of filing
No password to create and no card required. We store your email address, your watchlist and your preferences, nothing else.
PRIVACY & COOKIES
We track filings, not you.
Essential cookies keep you signed in and remember this choice.
Google Analytics 4 and Microsoft Clarity load only if you allow them here; they
count visits and record how pages are used. We run no advertising and never sell
data. Details in the privacy policy. Change this any time
via "Cookie settings" in the footer.